Literature DB >> 20663379

Clearance of Subarachnoid Clots after GDC Embolization for Acutely Ruptured Cerebral Aneurysm. Comparison with Early Direct Surgery.

S Kobayashi1, A Satoh, Y Koguchi, M Wada, H Tokunaga, A Miyata, H Nakamura, Y Watanabe, T Yagishita.   

Abstract

SUMMARY: It is apparent that subarachnoid clots play an important role in the development of delayed vasospasm that is one of the major causes of mortality and morbidity in patients with acutely ruptured cerebral aneurysm. The purpose of this study is to compare the clearance of subarachnoid clots in the acute stage after the treatment with Guglielmi detachable coils (GDC) and after treatment with direct surgery. Forty-nine patients were treated by GDC embolization within four days of the ictus. After GDC embolization, adjunctive therapies, such as ventricular and/or spinal drainage (67%), intrathecal administration of urokinase (41%), continuous cisternal irrigation (16%), and external decompression (16%), were performed. Seventy-four surgically treated patients were subsequently treated by continuous cisternal irrigation with mock-CSF containing ascorbic acid for ten days. The clearance of subarachnoid clots was assessed by the Hounsfield number serial changes on the CT scans taken on days 0, 4, 7, 10 after subarachnoid hemorrhage. The incidence of symptomatic vasospasm was lower in the GDC group (6%) than in the surgery group (12%). The clearance of subarachnoid clots from both the basal cistern and the Sylvian fissure was more rapid in the GDC cases than in the surgery cases in the first four days. Intrathecal administration of urokinase accelerated the clearance significantly. GDC embolization followed by intrathecal administration of thrombolytic agents accelerates the reduction of subarachnoid clots and favorably acts to prevent delayed vasospasm.

Entities:  

Year:  2002        PMID: 20663379      PMCID: PMC3627249          DOI: 10.1177/15910199010070S108

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  6 in total

1.  The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.

Authors:  J M Findlay; B K Weir; K Kanamaru; M Grace; R Baughman
Journal:  Neurosurgery       Date:  1990-02       Impact factor: 4.654

2.  Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.

Authors:  Y Murayama; T Malisch; G Guglielmi; M E Mawad; F Viñuela; G R Duckwiler; Y P Gobin; R P Klucznick; N A Martin; J Frazee
Journal:  J Neurosurg       Date:  1997-12       Impact factor: 5.115

3.  Frequency of cerebral vasospasm in patients treated with endovascular occlusion of intracranial aneurysms.

Authors:  K Yalamanchili; R H Rosenwasser; J E Thomas; K Liebman; C McMorrow; P Gannon
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

4.  Endovascular Treatment with GDC for Severe Acute SAH: Comparison with Early Direct Surgery.

Authors:  S Kobayashi; A Satoh; Y Koguchi; T Yamauchi; S Itoh; H Ooishi; H Nakamura; T Yagishita; Y Watanabe
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

5.  Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.

Authors:  M Usui; N Saito; K Hoya; T Todo
Journal:  Neurosurgery       Date:  1994-02       Impact factor: 4.654

6.  Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.

Authors:  K Mizoi; T Yoshimoto; A Takahashi; S Fujiwara; K Koshu; T Sugawara
Journal:  J Neurosurg       Date:  1993-03       Impact factor: 5.115

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.